Trials / Unknown
UnknownNCT04630704
Evaluating A Non-Invasive Tissue Perfusion Monitor
A Feasibility Study Evaluating A Non-Invasive Tissue Perfusion Monitor Utilising Diffuse Speckle Contrast Analysis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Pedra Technology, PTE LTD · Industry
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The Pedra perfusion system will be used to assess changes in perfusion in response to physiological stimuli. It will be compared to other standard diagnostics.
Detailed description
The Pedra perfusion system measures microvascular flow through diffuse speckle contrast analysis. It will be used to assess changes in perfusion in response to a number of physiological stimuli. It will be compared to other standard diagnostics including ankle-brachial index, toe-brachial index and transcutaneous oxygen measurement. Measurements will be undertaken in non-vascular patients as well as those with chronic limb threatening ischaemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pedra | Diffuse speckle contrast analysis perfusion system |
Timeline
- Start date
- 2020-12-07
- Primary completion
- 2021-04-01
- Completion
- 2021-07-01
- First posted
- 2020-11-16
- Last updated
- 2020-11-16
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04630704. Inclusion in this directory is not an endorsement.